These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

451 related items for PubMed ID: 28347704

  • 1. High glucose induced endothelial to mesenchymal transition in human umbilical vein endothelial cell.
    Yu CH, Suriguga, Gong M, Liu WJ, Cui NX, Wang Y, Du X, Yi ZC.
    Exp Mol Pathol; 2017 Jun; 102(3):377-383. PubMed ID: 28347704
    [Abstract] [Full Text] [Related]

  • 2. The role of miR-328 in high glucose-induced endothelial-to-mesenchymal transition in human umbilical vein endothelial cells.
    Chen Y, Yang Q, Zhan Y, Ke J, Lv P, Huang J.
    Life Sci; 2018 Aug 15; 207():110-116. PubMed ID: 29859985
    [Abstract] [Full Text] [Related]

  • 3. Crosstalk between endothelial cell-specific calpain inhibition and the endothelial-mesenchymal transition via the HSP90/Akt signaling pathway.
    Sun X, Sun Y, Jiang P, Qi G, Chen X.
    Biomed Pharmacother; 2020 Apr 15; 124():109822. PubMed ID: 31958767
    [Abstract] [Full Text] [Related]

  • 4. Celastrol protects TGF-β1-induced endothelial-mesenchymal transition.
    Gong F, Zhao F, Gan XD.
    J Huazhong Univ Sci Technolog Med Sci; 2017 Apr 15; 37(2):185-190. PubMed ID: 28397045
    [Abstract] [Full Text] [Related]

  • 5. Anti-Fibrosis Effect of Relaxin and Spironolactone Combined on Isoprenaline-Induced Myocardial Fibrosis in Rats via Inhibition of Endothelial-Mesenchymal Transition.
    Cai J, Chen X, Chen X, Chen L, Zheng G, Zhou H, Zhou X.
    Cell Physiol Biochem; 2017 Apr 15; 41(3):1167-1178. PubMed ID: 28245473
    [Abstract] [Full Text] [Related]

  • 6. Iron oxide nanoparticles induce reversible endothelial-to-mesenchymal transition in vascular endothelial cells at acutely non-cytotoxic concentrations.
    Wen T, Du L, Chen B, Yan D, Yang A, Liu J, Gu N, Meng J, Xu H.
    Part Fibre Toxicol; 2019 Jul 12; 16(1):30. PubMed ID: 31300057
    [Abstract] [Full Text] [Related]

  • 7. Protective effect of rapamycin on endothelial-to-mesenchymal transition in HUVECs through the Notch signaling pathway.
    Tian D, Zeng X, Wang W, Wang Z, Zhang Y, Wang Y.
    Vascul Pharmacol; 2019 Feb 12; 113():20-26. PubMed ID: 30336218
    [Abstract] [Full Text] [Related]

  • 8. Role of endothelial-to-mesenchymal transition induced by TGF-β1 in transplant kidney interstitial fibrosis.
    Wang Z, Han Z, Tao J, Wang J, Liu X, Zhou W, Xu Z, Zhao C, Wang Z, Tan R, Gu M.
    J Cell Mol Med; 2017 Oct 12; 21(10):2359-2369. PubMed ID: 28374926
    [Abstract] [Full Text] [Related]

  • 9. Protective Effect of Spironolactone on Endothelial-to-Mesenchymal Transition in HUVECs via Notch Pathway.
    Chen X, Cai J, Zhou X, Chen L, Gong Y, Gao Z, Zhang H, Huang W, Zhou H.
    Cell Physiol Biochem; 2015 Oct 12; 36(1):191-200. PubMed ID: 25967959
    [Abstract] [Full Text] [Related]

  • 10. Integrin β3 Mediates the Endothelial-to-Mesenchymal Transition via the Notch Pathway.
    Wang W, Wang Z, Tian D, Zeng X, Liu Y, Fu Q, Liang A, Zhang Y, Gao Q, Cheng J, Wang Y.
    Cell Physiol Biochem; 2018 Oct 12; 49(3):985. PubMed ID: 30196283
    [Abstract] [Full Text] [Related]

  • 11. Human cytomegalovirus promotes the activation of TGF-β1 in human umbilical vein endothelial cells by MMP-2 after endothelial mesenchymal transition.
    Chen G, Yang X, Wang B, Cheng Z, Zhao R.
    Adv Clin Exp Med; 2019 Nov 12; 28(11):1441-1450. PubMed ID: 31778596
    [Abstract] [Full Text] [Related]

  • 12. MALAT1 Modulates TGF-β1-Induced Endothelial-to-Mesenchymal Transition through Downregulation of miR-145.
    Xiang Y, Zhang Y, Tang Y, Li Q.
    Cell Physiol Biochem; 2017 Nov 12; 42(1):357-372. PubMed ID: 28535533
    [Abstract] [Full Text] [Related]

  • 13. A novel role of kallikrein-related peptidase 8 in the pathogenesis of diabetic cardiac fibrosis.
    Du JK, Yu Q, Liu YJ, Du SF, Huang LY, Xu DH, Ni X, Zhu XY.
    Theranostics; 2021 Nov 12; 11(9):4207-4231. PubMed ID: 33754057
    [Abstract] [Full Text] [Related]

  • 14. Transforming Growth Factor-β1 Induces Endothelial-to-Mesenchymal Transition via Akt Signaling Pathway in Renal Transplant Recipients with Chronic Allograft Dysfunction.
    Wang Z, Han Z, Tao J, Wang J, Liu X, Zhou W, Xu Z, Zhao C, Ju X, Wang Z, Tan R, Gu M.
    Ann Transplant; 2016 Dec 20; 21():775-783. PubMed ID: 27994216
    [Abstract] [Full Text] [Related]

  • 15. TGF-β1-induced SMAD2/3/4 activation promotes RELM-β transcription to modulate the endothelium-mesenchymal transition in human endothelial cells.
    Jiang Y, Zhou X, Hu R, Dai A.
    Int J Biochem Cell Biol; 2018 Dec 20; 105():52-60. PubMed ID: 30120989
    [Abstract] [Full Text] [Related]

  • 16. MiR-200a modulates TGF-β1-induced endothelial-to-mesenchymal shift via suppression of GRB2 in HAECs.
    Zhang H, Hu J, Liu L.
    Biomed Pharmacother; 2017 Nov 20; 95():215-222. PubMed ID: 28846982
    [Abstract] [Full Text] [Related]

  • 17. Relaxin inhibits cardiac fibrosis and endothelial-mesenchymal transition via the Notch pathway.
    Zhou X, Chen X, Cai JJ, Chen LZ, Gong YS, Wang LX, Gao Z, Zhang HQ, Huang WJ, Zhou H.
    Drug Des Devel Ther; 2015 Nov 20; 9():4599-611. PubMed ID: 26316699
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hepatocyte Growth Factor Attenuates the Development of TGF-β1- Induced EndMT through Down-regulating the Notch Signaling.
    Yang R, Yang F, Hu Y, Chen M, Liu Y, Li J, Zhong W.
    Endocr Metab Immune Disord Drug Targets; 2020 Nov 20; 20(5):781-787. PubMed ID: 31702496
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.